Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-041405

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Pablo Lapuerta
Officer — EVP and CMO
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———8,395D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$8.20Feb 11, 2016A67,640A—Feb 11, 2026Common Stock67,64067,640D
Restricted Stock Units (Phantom Stock)F2,F3—Feb 11, 2016A16,910A——Common Stock16,91016,910D
Stock Option (Right to Buy)F4$12.60holding————Feb 15, 2022Common Stock29,71429,714D
Restricted Stock Units (Phantom Stock)F2,F5—holding—————Common Stock1,8571,857D
Stock Option (Right to Buy)F6$14.63holding————Feb 8, 2023Common Stock39,99939,999D
Restricted Stock Units (Phantom Stock)F2,F7—holding—————Common Stock5,0005,000D
Stock Option (Right to Buy)F8$12.04holding————Feb 6, 2024Common Stock45,14245,142D
Restricted Stock Units (Phantom Stock)F2,F9—holding—————Common Stock8,4648,464D
Stock Option (Right to Buy)F10$6.23holding————Feb 5, 2025Common Stock72,79972,799D
Restricted Stock Units (Phantom Stock)F2,F11—holding—————Common Stock18,20018,200D
Stock Option (Right to Buy)F12$12.04holding————Mar 23, 2021Common Stock28,57128,571D

Explanation of responses